NIH-funded research R01 grant

ENaC channels and salt-sensitive blood pressure in immune cells

Official title: ENaC regulation and its role in blood pressure homeostasis

Funded at University of Pittsburgh at Pittsburgh · NIH-11412685 · Data updated 2026-11-12

This grant studies how a salt-sensing channel called ENaC in immune cells like dendritic cells and monocytes may influence blood pressure in people who are salt-sensitive.

More Blood Pressure research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startMay 1, 1996
Project endJune 30, 2029
Funding year2026
Award (this year)$719,887
NIH project number5R01HL147818-26
Project IDNIH-11412685 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with or at risk for salt-sensitive hypertension who may benefit from future therapies targeting ENaC in immune cells.

Less likely to help

Patients without salt-sensitive hypertension or those not involved in future trials may not directly benefit.

What this research studies

Researchers will explore how the ENaC d subunit, found in human immune cells but not in mouse kidney, affects blood pressure by transferring human-derived immune cells into immune-deficient mice. The project uses induced pluripotent stem cells to create dendritic cells and monocytes with or without the ENaC d subunit mutation, then examines their impact on blood pressure in a salt-rich environment. By analyzing how external salt, proteases, and channel modifications regulate ENaC activity, this work aims to connect genetic variants to salt-sensitive hypertension. Results could reveal new immune-cell targets for managing blood pressure in patients with salt sensitivity.

Why it matters

Potential benefit: If successful, the research could identify immune-cell ENaC pathways as new targets for treating salt-sensitive hypertension.

How similar studies have gone: Previous work linked ENaC gene variants to blood pressure, but the immune-cell specific role is a novel angle with early promise.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Kleyman, Thomas R — University of Pittsburgh at Pittsburgh
  • Study coordinator: Kleyman, Thomas R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.